Carcinoma, Renal Cell

Showing NaN - NaN of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))

Completed
  • Carcinoma, Renal Cell
  • Prostatic Neoplasms
  • FK228 (romidepsin)
  • Duarte, California
  • +4 more
Nov 14, 2019

Carcinoma, Renal Cell, Tumor Metastasis Trial in Duarte, Chicago, Seattle (FK228 (romidepsin))

Completed
  • Carcinoma, Renal Cell
  • Neoplasm Metastasis
  • FK228 (romidepsin)
  • Duarte, California
  • +2 more
Oct 16, 2019

Carcinoma, Renal Cell Trial in United States (RAD001)

Completed
  • Carcinoma, Renal Cell
  • Chicago, Illinois
  • +4 more
Mar 27, 2018

Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Chicago, Illinois
  • +6 more
Dec 18, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Interferon)

Completed
  • Carcinoma, Renal Cell
  • Sacramento, California
  • +41 more
Oct 24, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell Trial in Chicago (combination of gemcitabine, capecitabine, and bevacizumab)

Terminated
  • Carcinoma, Renal Cell
  • combination of gemcitabine, capecitabine, and bevacizumab
  • Chicago, Illinois
    University of Chicago
Jan 16, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Kidney Tumors, Carcinoma, Renal Cell Trial in United States (AG-013736 (axitinib))

Completed
  • Kidney Neoplasms
  • Carcinoma, Renal Cell
  • AG-013736 (axitinib)
  • Chicago, Illinois
  • +4 more
Jul 23, 2012

Carcinoma, Renal Cell, Kidney Tumors Trial in United States (ZD6126, Placebo)

Suspended
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Los Angeles, California
  • +15 more
Jan 25, 2011

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010

Carcinoma, Renal Cell Trial in United States (Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jan 6, 2010

Melanoma, Breast Tumors, Carcinoma, Renal Cell Trial in Germany, United States (PF-3512676)

Completed
  • Melanoma
  • +4 more
  • Berkely, California
  • +31 more
Mar 11, 2009

Carcinoma, Renal Cell Trial in United States (Recombinant Human Lactoferrin)

Completed
  • Carcinoma, Renal Cell
  • Recombinant Human Lactoferrin
  • Los Angeles, California
  • +5 more
Apr 8, 2008

Carcinoma, Renal Cell, Metastases, Tumor Trial in United States (GTI-2040)

Completed
  • Carcinoma, Renal Cell
  • Metastases, Neoplasm
  • Concord, California
  • +9 more
Jan 4, 2008

Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)

Completed
  • Carcinoma, Renal Cell
  • ABT-510/Thrombospondin-1 mimetic
  • Scottsdale, Arizona
  • +17 more
Aug 13, 2007